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Experimental 
HSA binding experiments. A ligand (quencher) can absorb energy at both the HSA excitation 
(280 nm) and emission (340 nm) wavelengths. In order to overcome the inner-filter effect, the 
absorbance values of the ligand used were measured and corresponding corrections were made 
during calculation of binding parameters according to the eq. (S1)S1: 
Fc= Fu × 10
(Aex × dex+ Aem × dem)/2 (eq. S1) 
where Fu is the measured emission fluorescence intensity, Fc is the corrected fluorescence 
intensity that would be measured in the absence of any inner-filter effects, dex and dem are the cell 
path lengths in the excitation and emission direction (1 cm), Aex and Aem are the absorbance 
values of the quencher measured at the excitation and peak emission wavelength. 
Fluorescence quenching data were processed using the Stern–Volmer eq. (S2): 
F0/F =1 + Ksv[Q] = 1+ kqτ0[Q  (eq. S2)  
where F0 and F are the HSA fluorescence intensities at 340 nm before and after addition of the 
quencher (Se-3-AP), Ksv is the Stern-Volmer quenching constant, kq stands for the fluorescence 
quenching rate constant, τ0 is the average fluorescence lifetime of the fluorophore  (7.09 ns for 
HSA)S2 and [Q] is the concentration of the quencherS3. The quenching process was additionally 
analyzed using a modified Stern–Volmer eq. (S3)S3: 
F0/F0–F = 1/ƒaKa [Q] +1/ƒa  (eq. S3) 
where F0 and F are the HSA fluorescence intensities before and after addition of the quencher at 
concentration [Q]. Ka represents the effective quenching constant for the accessible fluorophores, 
and ƒa is the fraction of accessible fluorophore. 
Thermodynamic parameters of binding, the enthalpy (ΔH) and entropy change (ΔS), 
during the binding of Se-3-AP to HSA were determined by measuring the binding constants at 
three temperatures, and following the Van’t Hoff eq. (S4): 
lnKa = – ΔH/RT + ΔS/R  (eq. S4) 
where R is the universal gas constant, T is the temperature (in K), and Ka is the effective 
quenching constant at the corresponding temperature. 
The estimations of association (binding) constants (Kb) and number of binding sites (n) of 
HSA and Se-3-AP were done using eq. (S5)S4: 
 
log(F0– F)/F= –nlog(1/([Q] – [P] × (F0– F)/F0)+nlogKb  (eq. S5)  
where [Q] and [P] are total concentrations of ligand (Se-3-AP) and protein (HSA), respectively. 
S4 
 
 
Figure S1. UV/vis spectrum of Se-3-AP (51 μM) in DMSO. 
 
 
 
Figure S2. Fluorescence spectrum of Se-3-AP (10 mM, λex = 360 nm) in DMSO. 
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Figure S3.1H-NMR spectrum of Se-3-AP in DMSO-d6. 
 
Figure S4.13C-NMR spectrum of Se-3-AP in DMSO-d6. 
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Figure S5. COSY spectrum of Se-3-AP in DMSO-d6. 
 
Figure S6. 1H-13C HSQC spectrum of Se-3-AP in DMSO-d6. 
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Figure S7. 1H-13C HMBC spectrum of Se-3-AP in DMSO-d6. 
 
 
Figure S8. 77Se-NMR spectrum of Se-3-AP in DMSO-d6. 
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Figure S9. Cyclic voltammograms of Se-3-AP and 3-APin 0.10 M [n-Bu4N]PF6/DMSO,  GC 
electrode. 
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Figure S10. Concentration-response curves and ED50 values for Se-3-AP on THP-1 (A) and 
MCF-7 cells (B) after 24 h treatment. Results are presented as percentages of apoptotic cells 
determined by means of Annexin V/propidium iodide double staining method for two 
independent experiments (circles and crosses), with asymmetric five-parameter sigmoidal curve 
computed for both replicates in GraphPad Prism software. 
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Figure S11. Changes in distribution of MCF-7 cells within phases of mitotic division induced by 
24 h treatment with 3-AP. Analysis has been performed on the same cell samples represented in 
Figure 2A (right panel) on the remaining cells after Annexin V/PI read out. Incidences of cells 
found at the G0/G1, S and G2/M phases were determined according to non-treated control 
population. Results represent percentages of cells within phases of cell cycle obtained from a 
single experiment considering additional replicates have not been acquired due to 3-AP lack of 
activity. 
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Figure S12. Stern-Volmer plot of F0/Fvs [Q] at three different temperatures, where F0 and F 
represent HSA fluorescence intensities in absence (F0) and in the presence of the quencher (F), 
and [Q] is the concentration of the quencher (Se-3-AP). 
 
 
Figure S13. Modified Stern-Volmer plot for binding of Se-3-AP to HSA at three temperatures. 
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Figure S14. The plot of lnKb vs 1/T for the interaction of Se-3-AP with HSA. Kb is given in M
–1. 
 
Figure S15.  Double-log plot for determination of binding constants Kb, and the number of 
binding sites n at three temperatures; concentration of the quencher [Q] is given in M. 
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